l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Invasiveness, Neoplasm

l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Noha, M; Teramoto, A; Watanabe, K; Yoshida, D	1

Other Studies

1 other study(ies) available for l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Invasiveness, Neoplasm

Article	Year
Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B. Journal of neuro-oncology, 2001, Volume: 52, Issue:1 Topics: Antineoplastic Agents; Collagen Type IV; Coloring Agents; Dipeptides; Glioma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Protease Inhibitors; Succinates; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2001

Article

Year

Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B.

Journal of neuro-oncology, 2001, Volume: 52, Issue:1

Topics: Antineoplastic Agents; Collagen Type IV; Coloring Agents; Dipeptides; Glioma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Protease Inhibitors; Succinates; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

2001